ACTIVE

BioSenic

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
22,2 M €
+458.0% YoY
Equity
-661,4 k €
-151.8% YoY

What does BioSenic do?

BioSenic is a Public limited company incorporated in 2006. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Tubize.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0882.015.654
Incorporation
22/06/2006
Legal form
Public limited company
Registered office
Avenue Léon Champagne 3
1480 Tubize · WallonieSee on map
Contributed capital
54 199 423,72 €
Latest accounts
31/12/2025
Activities (NACE)
72109Research and experimental development on natural sciences and engineering· main72190Other research and experimental development on natural sciences and engineering73100Advertising
Joint committees (2)
  • 116
  • 207
Contacts
4 public details availableLog in to view
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 9 financial years

202520142013201220112010200920082007
Income statement
Gross margin–4,3 M €4,6 M €4,4 M €3,1 M €1,9 M €-400,5 k €-327,1 k €-350,6 k €
EBITDA22,6 M €-74,9 k €2 M €1,4 M €-412,7 k €422,2 k €-1,1 M €-540,4 k €-489 k €
Operating result22,2 M €-6 M €-3,2 M €-2,5 M €-2,4 M €-348,4 k €-1,2 M €-542,3 k €-489 k €
Net result22,2 M €-6,2 M €-3,2 M €-2,5 M €-2,3 M €-251,8 k €-1,2 M €-534,3 k €-480,6 k €
Balance sheet
Equity-661,4 k €1,3 M €5,5 M €7,2 M €7,2 M €2,9 M €3,2 M €4,4 M €119,4 k €
Total assets3,4 M €26,5 M €16,7 M €17,7 M €14,7 M €11,7 M €5,2 M €4,6 M €435,6 k €
Cash67,1 k €10,1 M €588,1 k €2,1 M €2,9 M €5,1 M €1,8 M €3,7 M €15,5 k €
Debts4,1 M €19,8 M €5,5 M €5,4 M €3,8 M €7,1 M €1,9 M €199,6 k €316,3 k €
Other
Workforce–37,1 ETP38,1 ETP40,3 ETP42,1 ETP22,5 ETP11,1 ETP3,6 ETP2,5 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 57 ended

Active mandates

Anne-Sophie Jourdain

Mandate

Active
BOLETUS CONSULTING

Mandate · 0833.666.597

Active
Capital Grand Est

Mandate

Represented by Virginie Miath

Active
CarKath

Mandate · 0811.816.556

Represented by Eric Halioua

Active
FINSYS MANAGEMENT

Mandate · 0558.913.406

Represented by Jean-Luc Vandebroek

Active
IRYL Partners

Mandate · 1027.234.453

Active

Ended mandates

Paul MAGREZ

Director · since 05 février 2015 · until 23 mai 2019

Ended
Roland BARON

Director · since 05 février 2015 · until 23 mai 2019

Ended
ENRICO BASTIANELLI sprl

Managing director · since 16 janvier 2015 · until 23 mai 2019 · 0883.830.544

Represented by ENRICO BASTIANELLI

Ended
PARTIGEST-GARANCE SA

Director · since 16 janvier 2015 · until 25 mai 2017 · 0478.942.646

Represented by Jacques REYMANN

Ended
At this address

Other companies at this address

CompanyCBE no.
OpenS● Active
0821.802.905
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelFull modelConsolidated accountsConsolidated accountsFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date02/07/202601/12/202516/07/202417/07/202306/07/202224/06/2021
General meeting10/06/202630/10/202512/07/202414/06/202308/06/202209/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

29 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202510/06/202602/07/2026FrenchPDF
Full model31/12/202430/10/202501/12/2025FrenchPDF
Full model31/12/202312/07/202416/07/2024FrenchPDF
Consolidated accounts31/12/202312/07/202416/07/2024FrenchPDF
Full model31/12/202214/06/202305/07/2023FrenchPDF
Consolidated accounts31/12/202214/06/202317/07/2023FrenchPDF
Full model31/12/202108/06/202220/06/2022FrenchPDF
Consolidated accounts31/12/202108/06/202206/07/2022FrenchPDF
Full model31/12/202009/06/202124/06/2021FrenchPDF
Consolidated accounts31/12/202009/06/202123/06/2021FrenchPDF
Full model31/12/201910/06/202015/06/2020FrenchPDF
Consolidated accounts31/12/201910/06/202015/06/2020FrenchPDF
Full model31/12/201812/06/201920/06/2019FrenchPDF
Consolidated accounts31/12/201821/03/201920/06/2019FrenchPDF
Full model31/12/201713/06/201818/06/2018FrenchPDF
Consolidated accounts31/12/201713/06/201818/06/2018FrenchPDF
Full model31/12/201626/05/201708/06/2017FrenchPDF
Consolidated accounts31/12/201626/05/201708/06/2017FrenchPDF
Full model31/12/201526/05/201624/06/2016FrenchPDF
Consolidated accounts31/12/201526/05/201628/06/2016FrenchPDF
Abridged model31/12/201428/05/201526/06/2015FrenchPDF
Consolidated accounts31/12/201428/05/201529/06/2015FrenchPDF
Abridged model31/12/201322/05/201428/05/2014FrenchPDF
Abridged model31/12/201210/06/201311/07/2013FrenchPDF

View all 29 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 6 active · 57 ended

Active mandates

Anne-Sophie Jourdain

Mandate

Active
BOLETUS CONSULTING

Mandate · 0833.666.597

Active
Capital Grand Est

Mandate

Represented by Virginie Miath

Active
CarKath

Mandate · 0811.816.556

Represented by Eric Halioua

Active
FINSYS MANAGEMENT

Mandate · 0558.913.406

Represented by Jean-Luc Vandebroek

Active
IRYL Partners

Mandate · 1027.234.453

Active

Ended mandates

Paul MAGREZ

Director · since 05 février 2015 · until 23 mai 2019

Ended
Roland BARON

Director · since 05 février 2015 · until 23 mai 2019

Ended
ENRICO BASTIANELLI sprl

Managing director · since 16 janvier 2015 · until 23 mai 2019 · 0883.830.544

Represented by ENRICO BASTIANELLI

Ended
PARTIGEST-GARANCE SA

Director · since 16 janvier 2015 · until 25 mai 2017 · 0478.942.646

Represented by Jacques REYMANN

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates03/06/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Other20/04/2026
    DIVERS
    PDF
  • Other08/12/2025
    DIVERS
    PDF
  • Mandates17/10/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates15/09/2025
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Other09/05/2025
    DIVERS
    PDF
  • Capital / shares18/04/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Capital / shares08/04/2025
    CAPITAL, ACTIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202522,2 M €↑
  2. 2025
    Name changeBioSenic
  3. 2014
    Annual accounts 2014-6,2 M €↓
  4. 2013
    Annual accounts 2013-3,2 M €↓
  5. 2012
    Annual accounts 2012-2,5 M €↓
  6. 2011
    Annual accounts 2011-2,3 M €↓
  7. 2010
    Annual accounts 2010-251,8 k €↑
  8. 2009
    Annual accounts 2009-1,2 M €↓
  9. 2008
    Annual accounts 2008-534,3 k €↓
  10. 2007
    Annual accounts 2007-480,6 k €
  11. 2007
    Name changeBONE THERAPEUTICS
  12. 22/06/2006
    IncorporationPublic limited company